المؤلفون: Beier, Lea, Lu, Shihai, França, Lionel Riou, Marler, Sabrina, Lip, Gregory Y. H., Huisman, Menno V., Teutsch, Christine, Halperin, Jonathan L., Zint, Kristina, Diener, Hans-Christoph, Baker, Laurie, Ma, Chang-Sheng, Paquette, Miney, Bartels, Dorothee B., Dubner, Sergio J., Lyrer, Philippe, Senges, Jochen, Rothman, Kenneth J.

المصدر: Beier , L , Lu , S , França , L R , Marler , S , Lip , G Y H , Huisman , M V , Teutsch , C , Halperin , J L , Zint , K , Diener , H-C , Baker , L , Ma , C-S , Paquette , M , Bartels , D B , Dubner , S J , Lyrer , P , Senges , J & Rothman , K J 2022 , ' Evolution of antithrombotic therapy for patients with atrial fibrillation : The prospective global GLORIA-AF registry program ' ....

مصطلحات موضوعية: Administration, Oral, Anticoagulants/adverse effects, Atrial Fibrillation/chemically induced, Dabigatran/adverse effects, Fibrinolytic Agents/adverse effects, Humans, Registries, Stroke/chemically induced, Vitamin K

وصف الملف: application/pdf

العلاقة: https://vbn.aau.dk/da/publications/b741119e-881e-4fe6-9644-33b05ffb399aTest

الإتاحة: https://doi.org/10.1371/journal.pone.0274237Test
https://vbn.aau.dk/da/publications/b741119e-881e-4fe6-9644-33b05ffb399aTest
https://vbn.aau.dk/ws/files/490644140/Beier_et_al._2022_._Evolution_of_antithrombotic_therapy_for_patients_with_atrial_fibrillation_The_prospective_global_GLORIA_AF_registry_program.pdfTest
http://www.scopus.com/inward/record.url?scp=85139377485&partnerID=8YFLogxKTest

المؤلفون: Paquette, Miney^1,2 miney.paquette@boehringer-ingelheim.com, Riou França, Lionel³, Teutsch, Christine⁴, Diener, Hans-Christoph⁵, Lu, Shihai⁶, Dubner, Sergio J.⁷, Ma, Chang Sheng⁸, Rothman, Kenneth J.⁹, Zint, Kristina³, Halperin, Jonathan L.¹⁰, Huisman, Menno V.¹¹, Lip, Gregory Y.H.^12,13, Nieuwlaat, Robby¹

المصدر: Journal of the American College of Cardiology (JACC). Sep2017, Vol. 70 Issue 13, p1573-1583. 11p.

مصطلحات موضوعية: *ATRIAL fibrillation treatment, *DABIGATRAN, *ANTICOAGULANTS, *VITAMIN K, *STROKE prevention, *THERAPEUTICS, *VITAMIN therapy, *THERAPEUTIC use of proteins, *ATRIAL fibrillation, *DRUGS, *DRUG administration, *LONGITUDINAL method, *PATIENT compliance, *STROKE, *SOCIOECONOMIC factors, *DISEASE complications

المؤلفون: Paquette, Miney¹, Huisman, Menno¹, Lip, Gregory¹, Diener, Hans-Christoph¹, Dubner, Sergio¹, Halperin, Jonathan¹, Ma, Changsheng¹, Rothman, Kenneth¹, Teutsch, Christine¹, Lu, Shihai¹, Riou França, Lionel¹, Zint, Kristina¹, Bartels, Dorothee B.¹, Nieuwlaat, Robby¹

المصدر: Journal of the American College of Cardiology (JACC). Mar2017 Supplement, Vol. 69, p374-374. 1p.

مصطلحات موضوعية: *ATRIAL fibrillation, *ANTICOAGULANTS, *STROKE, *ISCHEMIA, *VITAMIN K, *PATIENTS

المؤلفون: Huisman, Menno V.¹, Rothman, Kenneth J.², Paquette, Miney³, Teutsch, Christine⁴, Diener, Hans Christoph⁵, Dubner, Sergio J.⁶, Halperin, Jonathan L.⁷, Ma, Changsheng⁸, Zint, Kristina⁴, Elsaesser, Amelie⁴, Bartels, Dorothee B.⁴, Lip, Gregory Y.H.⁹ g.y.h.lip@bham.ac.uk, GLORIA-AF Investigators (CORPORATE AUTHOR)

المصدر: American Journal of Medicine. Dec2015, Vol. 128 Issue 12, p1306-1313.e1. 1p.

مصطلحات موضوعية: *FIBRINOLYTIC agents, *ATRIAL fibrillation diagnosis, *ATRIAL fibrillation treatment, *ATRIAL fibrillation, *CLINICAL trials, *LONGITUDINAL method, *DRUG efficacy, *MEDICATION safety, *PATIENTS, *STROKE prevention, *ANTICOAGULANTS, *ASPIRIN, *COMPARATIVE studies, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *VITAMIN K, *EVALUATION research, *TREATMENT effectiveness, *ACQUISITION of data, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents